Danaher Corporation (DHR) Position Raised by Synovus Financial Corp

Synovus Financial Corp increased its position in shares of Danaher Corporation (NYSE:DHR) by 3.6% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 91,051 shares of the conglomerate’s stock after purchasing an additional 3,186 shares during the quarter. Synovus Financial Corp’s holdings in Danaher Corporation were worth $7,682,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Peddock Capital Advisors LLC increased its position in shares of Danaher Corporation by 17.4% during the 1st quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock worth $105,000 after purchasing an additional 181 shares in the last quarter. Proficio Capital Partners LLC increased its position in shares of Danaher Corporation by 92.3% during the 1st quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after purchasing an additional 598 shares in the last quarter. ClariVest Asset Management LLC acquired a new stake in shares of Danaher Corporation during the 1st quarter worth about $157,000. Motco increased its position in shares of Danaher Corporation by 8.8% during the 2nd quarter. Motco now owns 2,011 shares of the conglomerate’s stock worth $170,000 after purchasing an additional 163 shares in the last quarter. Finally, Cornerstone Advisors Inc. increased its position in shares of Danaher Corporation by 62.0% during the 2nd quarter. Cornerstone Advisors Inc. now owns 2,111 shares of the conglomerate’s stock worth $178,000 after purchasing an additional 808 shares in the last quarter. Institutional investors and hedge funds own 75.69% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece of content can be viewed at https://ledgergazette.com/2017/10/10/danaher-corporation-dhr-position-raised-by-synovus-financial-corp.html.

Danaher Corporation (NYSE DHR) opened at 87.03 on Tuesday. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.62. The company has a market cap of $60.46 billion, a price-to-earnings ratio of 27.78 and a beta of 1.03. The stock has a 50 day moving average of $85.25 and a 200 day moving average of $84.16.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The company had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. During the same quarter in the prior year, the firm posted $0.90 earnings per share. The firm’s revenue was up 6.3% compared to the same quarter last year. Equities research analysts predict that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be paid a $0.14 dividend. This represents a $0.56 annualized dividend and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 28th. Danaher Corporation’s dividend payout ratio is currently 17.83%.

In other news, Director Linda P. Hefner sold 10,578 shares of the company’s stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $83.03, for a total value of $878,291.34. Following the completion of the transaction, the director now owns 42,151 shares of the company’s stock, valued at $3,499,797.53. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider William King sold 7,458 shares of the company’s stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the transaction, the insider now directly owns 18,245 shares of the company’s stock, valued at approximately $1,513,787.65. The disclosure for this sale can be found here. Insiders sold 71,496 shares of company stock valued at $5,916,223 in the last ninety days. 12.20% of the stock is currently owned by insiders.

Several research firms have weighed in on DHR. Deutsche Bank AG restated a “buy” rating and issued a $97.00 price objective on shares of Danaher Corporation in a research report on Wednesday, June 21st. Morgan Stanley restated an “overweight” rating and issued a $95.00 price objective (up previously from $86.00) on shares of Danaher Corporation in a research report on Friday. Wells Fargo & Company began coverage on shares of Danaher Corporation in a research report on Thursday, July 13th. They issued a “market perform” rating and a $90.00 price objective for the company. Zacks Investment Research upgraded shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $91.00 price objective for the company in a research report on Friday, July 28th. Finally, BidaskClub cut shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Saturday, July 8th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $92.62.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research too

Other institutional investors have also recently made changes to their positions in the company. Peddock Capital Advisors LLC increased its position in shares of Danaher Corporation by 17.4% during the 1st quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock worth $105,000 after purchasing an additional 181 shares in the last quarter. Proficio Capital Partners LLC increased its position in shares of Danaher Corporation by 92.3% during the 1st quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after purchasing an additional 598 shares in the last quarter. ClariVest Asset Management LLC acquired a new stake in shares of Danaher Corporation during the 1st quarter worth about $157,000. Motco increased its position in shares of Danaher Corporation by 8.8% during the 2nd quarter. Motco now owns 2,011 shares of the conglomerate’s stock worth $170,000 after purchasing an additional 163 shares in the last quarter. Finally, Cornerstone Advisors Inc. increased its position in shares of Danaher Corporation by 62.0% during the 2nd quarter. Cornerstone Advisors Inc. now owns 2,111 shares of the conglomerate’s stock worth $178,000 after purchasing an additional 808 shares in the last quarter. Institutional investors and hedge funds own 75.69% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece of content can be viewed at https://ledgergazette.com/2017/10/10/danaher-corporation-dhr-position-raised-by-synovus-financial-corp.html.

Danaher Corporation (NYSE DHR) opened at 87.03 on Tuesday. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.62. The company has a market cap of $60.46 billion, a price-to-earnings ratio of 27.78 and a beta of 1.03. The stock has a 50 day moving average of $85.25 and a 200 day moving average of $84.16.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The company had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. During the same quarter in the prior year, the firm posted $0.90 earnings per share. The firm’s revenue was up 6.3% compared to the same quarter last year. Equities research analysts predict that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be paid a $0.14 dividend. This represents a $0.56 annualized dividend and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 28th. Danaher Corporation’s dividend payout ratio is currently 17.83%.

In other news, Director Linda P. Hefner sold 10,578 shares of the company’s stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $83.03, for a total value of $878,291.34. Following the completion of the transaction, the director now owns 42,151 shares of the company’s stock, valued at $3,499,797.53. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider William King sold 7,458 shares of the company’s stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the transaction, the insider now directly owns 18,245 shares of the company’s stock, valued at approximately $1,513,787.65. The disclosure for this sale can be found here. Insiders sold 71,496 shares of company stock valued at $5,916,223 in the last ninety days. 12.20% of the stock is currently owned by insiders.

Several research firms have weighed in on DHR. Deutsche Bank AG restated a “buy” rating and issued a $97.00 price objective on shares of Danaher Corporation in a research report on Wednesday, June 21st. Morgan Stanley restated an “overweight” rating and issued a $95.00 price objective (up previously from $86.00) on shares of Danaher Corporation in a research report on Friday. Wells Fargo & Company began coverage on shares of Danaher Corporation in a research report on Thursday, July 13th. They issued a “market perform” rating and a $90.00 price objective for the company. Zacks Investment Research upgraded shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $91.00 price objective for the company in a research report on Friday, July 28th. Finally, BidaskClub cut shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Saturday, July 8th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $92.62.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply